Kaleido Biosciences, Inc.

CIK 1751299 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kaleido Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
May 10, 2022SC 13G/A0000315066-22-001584
May 6, 202215-12B0001193125-22-143056
Apr 29, 2022EFFECT9999999995-22-001166
Apr 25, 2022S-8 POS0001193125-22-117713
Apr 25, 2022POS AM0001193125-22-117697
Apr 25, 2022S-8 POS0001193125-22-117703
Apr 25, 2022S-8 POS0001193125-22-117709
Apr 18, 2022250001193125-22-107467
Apr 8, 20228-K0001193125-22-099802
Apr 1, 202210-K0000950170-22-005256
Apr 1, 2022NT 10-K0001193125-22-092327
Mar 17, 20228-K0000950170-22-004108
Mar 9, 20228-K0000950170-22-003232
Mar 2, 202240001209191-22-014673
Mar 2, 202240001209191-22-014692
Feb 9, 2022SC 13G/A0000315066-22-001057
Jan 28, 20228-K0000950170-22-000560
Jan 18, 202240001209191-22-003530
Jan 18, 202240001209191-22-003532
Jan 18, 202240001209191-22-003526
Jan 18, 202240001209191-22-003534
Jan 18, 202240001209191-22-003528
Dec 16, 202130001209191-21-070015
Dec 16, 202140001209191-21-070022
Nov 1, 202110-Q0000950170-21-002534